The Tumor Lysis Syndrome
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
The tumor lysis syndrome is the most common disease-related emergency in children and adults with hematologic cancers. This review summarizes current strategies for risk assessment, prophylaxis, and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An important consideration with respect to safety in patients that may have a compromised immune system is that engineered bacterial products are likely to engage both innate and adaptive immunity in the event of release of the organism into the body following tumor lysis75, triggering inflammatory responses.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [75]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802639 · Cited by 1,759
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Self-citationTumour lysis syndrome: new therapeutic strategies and classification
Cairo, M. S., & Bishop, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05094.x · Cited by 1,076
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
Coiffier, B., Altman, A., Pui, C.-H., Younes, A., & Cairo, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0177 · Cited by 792
Self-citationCairo, M. S., Coiffier, B., Reiter, A., Younes, A., & Panel, O. B. O. T. T. E. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08143.x · Cited by 570
Goldman, S. C., Holcenberg, J. S., Finklestein, J. Z., Hutchinson, R., Kreissman, S., Johnson, F. L., Tou, C., Harvey, E., Morris, E., & Cairo, M. S. (2001) · Blood · doi:10.1182/blood.v97.10.2998 · Cited by 477
Cairo, M. S., Gerrard, M., Sposto, R., Auperin, A., Pinkerton, C. R., Michon, J., Weston, C., Perkins, S. L., Raphael, M., McCarthy, K., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036665 · Cited by 363
Pui, C.-H., Mahmoud, H. H., Wiley, J. M., Woods, G. M., Leverger, G., Camitta, B., Hastings, C., Blaney, S. M., Relling, M. V., & Reaman, G. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.697 · Cited by 361
Self-citationOral Phosphate Binders in Patients with Kidney Failure
Tonelli, M., Pannu, N., & Manns, B. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912522 · Cited by 339
Cited by
Items 601–700 of 1,000
A Rare Cause of Tumour Lysis Syndrome and Acute Kidney Injury
Ali, A., & Al-Janabi, R. D. (2020) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2020.109 · Cited by 3
Desai, M. H., Parsi, M., Potdar, R. R., & Sanjay, R. (2020) · Cureus · doi:10.7759/cureus.11279 · Cited by 3
“Intrinsic tumor qualities that increase the risk of TLS include rapid proliferative rate of the cancer, bulky tumors defined as greater than 10 cm in diameter or a white blood cell count greater than 50,000, involvement of bone marrow or other organs, and high chemosensitivity [15].”
BackgroundNon-targeted Drugs for Cancer Therapy
Baldo, B. A., & Pham, N. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-51740-3_15 · Cited by 3
Khaleghi, R., & Asad, S. (2021) · 3 Biotech · doi:10.1007/s13205-021-02670-6 · Cited by 3
“Hyperuricemia plays an essential role in cardiac–kidney–vascular diseases, gout, and tumor lysis syndrome (Howard et al. 2011; Richette and Bardin 2010; Wang et al. 2018).”
BackgroundCongenital Diaphragmatic Hernia
Aina, T. A. O. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.023 · Cited by 3
Hossain, S., Naber, M., & Yacobucci, M. J. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552211021147 · Cited by 3
“Tumor lysis syndrome (TLS) is an oncologic emergency caused by rapid cancer cell death.(1) Unregulated lysis, either spontaneous or caused by chemotherapy, targeted therapy, or radiation, leads to the release of intracellular molecules into the extracellular space, culminating in metabolic and electrolyte imbalances i…”
BackgroundHanafi, A. R., Jayusman, A. M., Imelda, P., Alfasunu, S., Sadewa, A. H., Pramono, D., Heriyanto, D. S., Haryana, S. M., & Kresno, S. B. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05852-w · Cited by 3
“In some cases, hyperkalemia in TLS could be worsening and it causes arrhythmia to death [21, 22].”
BackgroundInfluentialSandlund, J. T., & Onciu, M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00094-3 · Cited by 3
Real-world incidence of venetoclax toxicities in British Columbia
Lee, C., Markarian, A., Ladha, F., Nakashima, L., de Lemos, M. L., Schaff, K., Woo, S. M.-L., & Gerrie, A. S. (2022) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552221084616 · Cited by 3
“It manifests as laboratory abnormalities with possible clinical features such as cardiac arrhythmia, seizure, or death,(2,4) and standardized diagnostic criteria have been developed.(5) Risk factors for TLS include bulky disease (as quantified by largest lymph node diameter and absolute lymphocyte count),”
BackgroundMethodInfluentialRescue Therapies for AKI in Onconephrology: Rasburicase and Glucarpidase
Latcha, S., & Shah, C. V. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2023.151342 · Cited by 3
Khouderchah, C. J., Benitez, L. L., Marini, B. L., Fraga, M. S., Pettit, K. M., Burke, P. W., Bixby, D. L., & Perissinotti, A. J. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2276056 · Cited by 3
“Moreover, the use of the Cairo-Bishop criteria may overestimate the incidence of TLS compared to the Howard criteria, as it does not require two simultaneous electrolyte abnormalities [9].”
MethodHoward, S. C., Ribeiro, R. C., & Pui, C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.030 · Cited by 3
Self-citationAcute Kidney Injury in Cancer Patients
Angelo, J., & Samuels, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415948-8.00002-7 · Cited by 3
Oncologic Emergencies in Pediatric Patients: What Oncology Nurses Need to Know
Theis, J. (2014) · Oncology Times · doi:10.1097/01.cot.0000446235.58761.12 · Cited by 3
Approved Biologics Used for Therapy and Their Adverse Effects
Baldo, B. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-30472-4_1 · Cited by 3
Urae, S., Tsuruoka, K., Kuroya, S., & Shibagaki, Y. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6659 · Cited by 3
“3 mg/dL) met the clinical criteria for TLS (3), while no arrhythmia, seizure, nausea, lethargy or tetany was seen.”
BackgroundMethodImmunochem Immunopathol: Open Access
Khosla, M., Lim, V. M., & Bering, J. (2015) · Immunochemistry & Immunopathology · doi:10.4172/2469-9756.1000101 · Cited by 3
“Additionally, allopurinol and rasburicase should be given to patients undergoing chemotherapy to prevent Tumor Lysis Syndrome [9].”
BackgroundOncological emergencies: tumor lysis syndrome.
Sobota, J., Püsküllüoglu, M., & Zygulska, A. L. (2014) · PubMed · Cited by 3
Medical Supportive Care for Treatment-Related Toxicity in Childhood ALL
Orgel, E., & Bhojwani, D. (2017) · Springer eBooks · doi:10.1007/978-3-319-39708-5_12 · Cited by 3
Chronic Lymphocytic Leukemia and the Kidney
Sethi, A., Rhodes, J. M., Mato, A. R., & Hogan, J. J. (2017) · Journal of Onco-Nephrology · doi:10.5301/jo-n.5000022 · Cited by 3
“Tumor lysis syndrome (TLS) occurs when intracellular components (specifically potassium, phosphorus, and nucleic acids) are released into the systemic circulation by massive cell turnover and cell lysis.”
BackgroundMethodInfluentialSandlund, J. T., & Onciu, M. M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00097-7 · Cited by 3
Howard, S. C. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00038-2 · Cited by 3
Self-citationPark, Y., Chung, B. H., Park, C. W., Kim, Y., & Yang, C. W. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01903-9 · Cited by 3
Tumor lysis syndrome: still the Achilles heel of venetoclax in treatment of CLL?
Anderson, M. A., & Seymour, J. F. (2020) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2020.1802454 · Cited by 3
Fatal tumor lysis syndrome in a patient with metastatic gastric adenocarcinoma
Moiseff, R., Felty, C. C., & Liu, X. (2020) · Autopsy and Case Reports · doi:10.4322/acr.2020.225 · Cited by 3
Things We Do For No Reason™: Rasburicase for Adult Patients With Tumor Lysis Syndrome
Niforatos, J. D., Zheutlin, A. R., Chaitoff, A. M., & Hilal, T. (2021) · Journal of Hospital Medicine · doi:10.12788/jhm.3618 · Cited by 3
Tsuchie, H., Miyakoshi, N., Nagasawa, H., & Shimada, Y. (2021) · Institutional Repositories DataBase (IRDB) · doi:10.18926/amo/62408 · Cited by 3
Baijal, R. G., & Patel, N. V. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.029 · Cited by 3
Non-viral transfection efficiencies for the advancement of CAR-T therapy.
Murphy, E. M. (2019) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3248 · Cited by 3
Associations between Allopurinol and Cardiovascular and Renal Outcomes in Diabetes
Weisman, A. (2020) · TSpace (University of Toronto) · Cited by 3
Kalali, D. (2023) · Oncology in Clinical Practice · doi:10.5603/ocp.96314 · Cited by 2
“The latter syndrome occurs when destroyed cancerous cells release their contents into the bloodstream and since potassium concentrations are relatively high in the intracellular fluid, hyperkalemia is often induced [36, 37].”
Prasertsan, P., McNeil, E. B., Songthawee, N., Chavananon, S., Sripornsawan, P., Chaisujyakorn, T., & Chotsampancharoen, T. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2390582 · Cited by 2
“A laboratory diagnosis of TLS was based on the Cairo-Bishop and Howard criteria [5,11] defined as two or more of the following laboratory test results: potassium ≥ 6 mmol/L, phosphate ≥ 6.5 mmol/L, calcium ≤ 7 mmoL/L, and/or uric acid ≥ 8 mmol/L.”
InfluentialIto, T., Kamimura, T., Kiguchi, T., Kato, K., Takenaka, R., Kobayashi, M., Ito, A., Sakai, M., & Izutsu, K. (2024) · International Journal of Hematology · doi:10.1007/s12185-024-03832-x · Cited by 2
“Although comparisons across trials should be made with caution due to differences in study populations and trial methods, overall, the results of this study support the TLS occurs when tumor cells release their contents into the bloodstream spontaneously or in response to therapy [11].”
ResultXiao, Y., Xiao, L., Xu, X., Guan, X., Guo, Y., Shen, Y., Lei, X., Dou, Y., & Yu, J. (2024) · Leukemia Research · doi:10.1016/j.leukres.2024.107587 · Cited by 2
Berton, G., Garciaz, S., Rouzaud, C., Maisano, V., Hicheri, Y., D’Incan, E., Rey, J., Bisbal, M., Sannini, A., Chow‐Chine, L., et al. (2025) · European Journal Of Haematology · doi:10.1111/ejh.14366 · Cited by 2
Acute Kidney Injury and Critical Care Nephrology
Bonilla, M., Koyner, J. L., & Neyra, J. A. (2025) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2024.12.002 · Cited by 2
Cairo, M. S., Gallagher, J. R., Barnes, Y. J., Drea, E., Clark, C., & Carroll, S. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-10090-y · Cited by 2
“UA can induce acute kidney injury by intrarenal crystals and by crystal-independent mechanisms such as renal vasoconstriction [4–7].”
Cui, K., Wan, J., Li, Z., Zhao, J., Qin, Y., Hao, S., & Huang, F. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06824-5 · Cited by 2
“This observed improvement may be attributed to both pharmacokinetic optimization and DEX’s anti-inflammatory effects, which suppress TNF-α and IL-6 release and stabilize vascular permeability systems.”
Fluid and Electrolyte Abnormalities in Patients with Cancer
Abudayyeh, A., Abdelrahim, M., & Salahudeen, A. K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415948-8.00011-8 · Cited by 2
Hematology and Oncology in Critical Illness
Brandão, L. R., Howard, S. C., Gow, K. W., Rajasekaran, S., & Tamburro, R. F. (2011) · Springer eBooks · doi:10.1007/978-0-85729-923-9_38 · Cited by 2
“In contrast, rasburicase removes uric acid by enzymatically degrading it into allantoin, a highly soluble product that has no known adverse effects on health (Howard et al.”
BackgroundSelf-citationSpontaneous Tumor Lysis Syndrome in a Thoracic Burkitt Lymphoma: A Case Report
Figueiredo, A., Pimentel, J., Figueira, M., & Neves, A. (2024) · Cureus · doi:10.7759/cureus.73084 · Cited by 2
Burkitt lymphoma after adult liver transplantation: a case report and literature review
Zhang, J., Chen, Q., & Zhang, S. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1439137 · Cited by 2
T-cell Prolymphocytic Leukemia, Cerebriform Variant
Carvalho, J., Esteves, A., da Silva, F. T., Couto, J. P., & Ribeiro, C. (2021) · Cureus · doi:10.7759/cureus.13299 · Cited by 2
Sinton, J. W., & Ryan, W. D. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.016 · Cited by 2
Wahab, A., Rafae, A., Mushtaq, K., Venkata, K. V. R., & Rehan, S. (2021) · American Journal of Case Reports · doi:10.12659/ajcr.932081 · Cited by 2
“5 mg/dl), and hypocalcemia (£7 mg/dl), which eventually cause clinical toxicities in the form of acute kidney failure, seizures, arrhythmias, and death [1,2].”
BackgroundKoneru, H., PATTISAPU, A. K. K., & Bozyk, P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-26710-0_81 · Cited by 2
Masamayor, E. M. I., Besa, J. J. V., Tan‐Lim, C. S. C., Pajes, A. N. N. I., & Palileo‐Villanueva, L. M. (2022) · Asian Journal of Oncology · doi:10.1055/s-0042-1750701 · Cited by 2
Hematologic and Oncologic Emergencies
Holden, K., Rao, S., White, R., Bangash, S. A., Madgula, A. S., Schmetzer, A., Sangli, S. S., Ivanova, V., & Balaan, M. R. (2022) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000440 · Cited by 2
Kawamoto, T., Karino, T., Muramoto, Y., Oshima, M., Kosugi, Y., & Shikama, N. (2023) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10210 · Cited by 2
Lee, M., & Sandhu, M. (2023) · Cureus · doi:10.7759/cureus.36305 · Cited by 2
“If these methods are insufficient, hemodialysis and hemofiltration would be needed to lower potassium levels since this would likely occur with damage to the kidneys, as seen with our patient [14].”
BackgroundMethodInfluentialPost-operative Tumor Lysis Syndrome in High-Grade Uterine Sarcoma
Qasim, H., Mahadevia, H. J., Ponvilawan, B., Hamdan, H., & Shrestha, A. (2023) · Cureus · doi:10.7759/cureus.37956 · Cited by 2
“It is a constellation of metabolic derangements commonly observed in high-grade hematological malignancies [1], especially in high-grade B-cell lymphomas, such as Burkitt lymphoma and acute lymphocytic leukemia.”
BackgroundTargeting Cancer Metabolism Dependencies
Harding, K. (2023) · CABI eBooks · doi:10.1079/9781789245820.0004 · Cited by 2
Rasburicase-induced methemoglobinemia and haemolytic anaemia in a patient with G6PD deficiency
Surya, N., Wu, C., & Ryan, H. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-262830 · Cited by 2
Spontaneous Tumor Lysis Syndrome as a Complication of Metastatic Breast Cancer: A Rare Case Report
Emadzadeh, A., Saffari, A., & Emadzadeh, M. (2025) · Journal of Kidney Diseases · doi:10.61882/ijkd.19.2.127 · Cited by 2
Thau, S., Poulsen, C. B., Larsen, M. K., & Pedersen, L. M. (2025) · Advances in Hematology · doi:10.1155/ah/3910332 · Cited by 2
Chou, T., Wu, C.-F., Lin, C., & Hsu, C. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1624908 · Cited by 2
“The clinical course, together with laboratory and imaging fi ndings, ultimately pointed to TLS, a very uncommon complication in this setting (3, 11).”
Fadi, M., Lahlou, F. A., Ouafa, Y. E., Chahdi, H., & Bouanani, N. (2025) · Cureus · doi:10.7759/cureus.93185 · Cited by 2
Boddapati, S. N. M., Kola, A. E., & Suggisetti, V. K. (2020) · Journal of Advanced Scientific Research · Cited by 2
Acute Kidney Injury: Epidemiology and Assessment
Hilton, R. M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5547-8_5 · Cited by 2
Baldo, B. A., & Pham, N. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7261-2_13 · Cited by 2
50-Year-Old Man With New-Onset Acute Kidney Injury
Melendez-Rosado, J., Zetir, M., & Stancampiano, F. F. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.04.027 · Cited by 2
“The mechanism of kidney injury in TLS is multifactorial and involves increased crystallization of uric acid in renal tubules, tubular obstruction from cell sloughing, crystal-independent mechanisms such as uric acideinduced renal vasoconstriction, and calcium-phosphate complex precipitation.(2,3)”
BackgroundHow to recognize and treat childhood leukemia
Zappolo, K., DeFeo, D., Dang, D., & Covino, J. M. (2013) · JAAPA · doi:10.1097/01.jaa.0000431503.15874.2e · Cited by 2
Marin, G. H., & Majek, E. (2012) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2012.e118 · Cited by 2
Venkatesan, R. (2015) · International Journal of Cancer and Oncology · doi:10.15436/2377-0902.15.016 · Cited by 2
“A diagnosis of ARF secondary to acute urate nephropathy was made.”
BackgroundInfluentialTumor Lysis Syndrome: An Unreported Complication of Intrathecal Ara-C
Simangan, L. R., & Kline, R. M. (2014) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000188 · Cited by 2
Glasser, C. L. (2017) · Leukemia Research Reports · doi:10.1016/j.lrr.2017.10.002 · Cited by 2
“TLS is characterized by hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia which can lead to life-threatening complications including dysrhythmias, seizures, and renal failure [1,2].”
BackgroundMarsh, A., Agrawal, A. K., & Feusner, J. H. (2014) · Pediatric oncology · doi:10.1007/978-3-662-44317-0_3 · Cited by 2
Muniz, P. C., Landgraf, M. M., Picon, F. S., Tadokoro, H., de Mello, R. A., & de Almeida, M. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-16245-0_42 · Cited by 2
Use of Denosumab in a Patient with Non–Small-Cell Lung Cancer and Severe Renal Function Impairment
Govaerts, E., & Vansteenkiste, J. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318284375c · Cited by 2
Kim, S. H., Yang, E. J., Kim, S. Y., & Kim, S. Y. (2017) · Journal of the Korean Society of Pediatric Nephrology · doi:10.3339/jkspn.2017.21.1.31 · Cited by 2
Koneru, H., & Bozyk, P. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-43341-7_75 · Cited by 2
Das Tumorlysesyndrom: Mehr als ein Hyperurikämie-induziertes akutes Nierenversagen
Nußhag, C., Fink, S., & Zeier, M. G. (2015) · Der Nephrologe · doi:10.1007/s11560-015-0028-z · Cited by 2
“Letztere tritt vor allem bei mehrmaliger Applikation nach vorheriger Sensibilisierung auf [12, 25].”
BackgroundInfluentialAnaphylactic Shock Following Repeated Rasburicase Treatment
Alaya, S., Mofredj, A., Darmon, N., Tassaioust, K., & Mrabet, A. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017740599 · Cited by 2
Spontaneous tumor lysis syndrome in a giant neglected breast cancer.
Cordrey, E. O., Dienhart, J. A., & Wang, J. (2018) · doi:10.35841/molecular-oncology.2.2.38-41 · Cited by 2
Oncologic Emergencies in Pediatric Critical Care
Cortés, J. A., & Mejia, R. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-74588-6_132 · Cited by 2
Hsiao, H., Du, J., & Cheng, Y. (2019) · Journal of Cancer Research and Practice · doi:10.4103/jcrp.jcrp_18_19 · Cited by 2
“[4] TLS often occurs within 7 days of cytotoxic treatment, and patients with chronic kidney disease are at increased risk.[5] Spontaneous TLS involves cell lysis with excessive nucleic acids in patients who have not undergone cytotoxic therapy.”
BackgroundAnesthesia for Cardiac Catheterization
Sinton, J. W. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.064 · Cited by 2
Acute kidney injury in a patient with lymphoma
Perazella, M. A. (2020) · Journal of Onco-Nephrology · doi:10.1177/2399369319899098 · Cited by 2
Intercorrências onco-hematológicas
Nadas, G., Mucillo, G., Silva, N. F., & Silveira, V. (2019) · Unesc eBooks · doi:10.18616/hema10 · Cited by 2
Wafa, A., Jarjour, R. A., Alolabi, D., Liehr, T., Hamdan, O., Melo, J. B., Carreira, I. M., Othman, M. A. K., & Achkar, W. A. (2020) · Molecular Cytogenetics · doi:10.1186/s13039-020-00512-3 · Cited by 2
Acute Tumor Lysis Syndrome: A Metabolic Emergency in Cancer Patients
Attinà, G., Tepedino, R., & Ruggiero, A. (2021) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2273 · Cited by 2
Huang, Y., Huang, F., Tsai, S.-F., Jan, S., & Fu, L. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.12.006 · Cited by 2
Management of oncologic emergencies
Freedman, J. L., Elgarten, C. W., & Rheingold, S. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821671-2.00009-x · Cited by 2
Torres, G. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.013 · Cited by 2
Supriyadi, E. (2015) · Springer eBooks · doi:10.1007/978-3-319-21683-6_43 · Cited by 2
Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical care
Chapman, R., Shah, S., & D’Angelo, A. (2022) · Journal of the Intensive Care Society · doi:10.1177/17511437221106441 · Cited by 2
“The incidence of TLS depends on a myriad of factors, such as cancer type, tumour burden, therapy given and pre-existing renal function.(3) As a result, the incidence can range greatly from as low as 4%, up to 30% in certain patient groups.”
BackgroundIntestinal obstruction from calcium polystyrene sulfonate in pediatric cancer patients
Getsuwan, S., Komwilaisak, P., Laoaroon, N., Tanming, P., Suwannaying, K., Wiangnon, S., & Jetsrisuparb, A. (2022) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2022.07.001 · Cited by 2
Al-Mashdali, A. F., & Yassin, M. A. (2022) · Medicine Case Reports and Study Protocols · doi:10.1097/md9.0000000000000244 · Cited by 2
Kobayashi, S., Yasu, T., & Akazawa, M. (2022) · Current Oncology · doi:10.3390/curroncol29120772 · Cited by 2
“In clinical practice, it is assumed that rasburicase re-administration may be required during repeated courses of cancer chemotherapy in patients at a high risk of TLS.”
BackgroundInfluentialTumor Lysis Syndrome Induced by Tebentafusp
Ruf, T., Leonhardt, A., Anz, D., Kunz, W. G., Röhrle, N., Foerster, P. I., Tomsitz, D., French, L. E., Seegräber, M., & Heinzerling, L. M. (2023) · Immunotherapy · doi:10.2217/imt-2023-0093 · Cited by 2
Kawaji, T., Okamoto, A., Moriyama, K., Hayakawa, S., Tomita, A., Hara, Y., Kuriyama, N., Nakamura, T., & Nishida, O. (2023) · Renal Replacement Therapy · doi:10.1186/s41100-023-00506-y · Cited by 2
“Although the indications for kidney replacement therapy (KRT) in patients with TLS are similar to those in patients with other causes of AKI, lower thresholds are used in patients with TLS because of potentially rapid potassium release and accumulation, particularly in patients with oliguria [10].”
BackgroundCalle, M. G., Valdez, S., & Quiroz, E. I. G. (2023) · Oncología (Ecuador) · doi:10.33821/728 · Cited by 2
Banerji, V., Aw, A., Laferriere, N., Abdel‐Samad, N., Peters, A., Johnson, N. A., Bernard, M.-P., Gopalakrishnan, S. K., Bull, S.-J., Fournier, P., et al. (2024) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2301738 · Cited by 2
“…risk mitigation (e.g. prophylaxis treatments, prophylactic hospitalization, fluid replacement therapy), TLS monitoring (e.g. changes in serum potassium, creatinine, uric acid, phosphorus [phosphate], and calcium, and presence of clinical or laboratory TLS as assessed using Howard’s criterion) [3].”
MethodSafety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies
Roeker, L. E., Coombs, C. C., Shah, N. N., Jurczak, W. J., Woyach, J. A., Cheah, C. Y., Patel, K., Maddocks, K. J., Wang, Y., Zinzani, P. L., et al. (2024) · Acta Haematologica · doi:10.1159/000539587 · Cited by 2
Müller, A. M. S. (2024) · healthbook TIMES Oncology Hematology · doi:10.36000/hbt.oh.2024.20.147 · Cited by 2
Esophageal Atresia and Tracheoesophageal Fistula
Adler, A. C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.021 · Cited by 2
Leucemia Linfocítica Crónica Tipo B
Pescada, C. P. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/2ftq-6q74 · Cited by 2
ACUTE KIDNEY INJURY IN CHILDREN WITH LEUKEMIA
Grevtseva, E., Nastausheva, T. L., Volosovets, G. G., & Yudina, N. B. (2017) · Nephrology (Saint-Petersburg) · doi:10.24884/1561-6274-2017-3-61-68 · Cited by 1
“Описаны случаи синдрома лизиса опухоли с развитием ОПП на фоне химиотерапии Т-клеточного острого лимфобластного лейкоза (ОЛЛ) [12, 13].”
da Silva, G. S., Fernandes, L. L., & Pereira, T. T. (2022) · Springer eBooks · doi:10.1007/978-3-030-98596-7_10 · Cited by 1
Onco-Nephrology in the Critical Care Setting
Frost, K. (2022) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2022.07.002 · Cited by 1
Metadata
- Authors
- Howard, S. C., Jones, D. P., & Pui, C.-H.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-05-12
- Volume
- 364
- Issue
- 19
- Pages
- 1844-1854
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3437249
- OpenAlex
- W2122479144
- Cited by
- 1,044
- References
- 58
- Citations by year
- 2026: 71 · 2025: 67 · 2024: 86 · 2023: 71 · 2022: 69 · 2021: 81 · 2020: 89 · 2019: 154 · 2018: 60 · 2017: 53 · 2016: 49 · 2015: 57 · 2014: 47 · 2013: 49 · 2012: 31
- FWCI
- 36.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA21765, P30CA021765)
- National Institute of General Medical Sciences (U01GM92666, U01GM092666)
- Topics
- Health Sciences › Medicine › Hematology › Methemoglobinemia and Tumor Lysis Syndrome
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Surgery › Muscle and Compartmental Disorders
- Keywords
- tumor lysis syndrome, hematologic malignancies, risk assessment, prophylaxis, treatment, pediatric oncology, emergency management
- MeSH terms
- Child, Humans, Male, Tumor Lysis Syndrome, Risk Assessment, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.